³Ô¹ÏÍøÕ¾

Latest bladder cancer News

5000 Cyclists Saddle Up In Fight Against Cancer
For 50,000 Australians October 5 is the one day each year when they can be seen and heard
Hon Dr Shane Reti: ³Ô¹ÏÍøÕ¾ delivers first cancer medicines from $604m boost
Pharmac delivering more for Kiwis following major funding boost
Queensland researchers identify potential new treatment pathway for bladder cancer
Potential New Treatment Pathway For Bladder Cancer
Three animals that can detect disease in humans
Bladder Cancer MRI Trial Taking Place In Hunter
2023 Interim Review of the List of Deemed Disease in Australia report
Technology shines a light on better bladder cancer detection
June is leaving a gift in her Will towards cancer research
Unbreakable Amy Is Still Beating Cancer After 21 Years
Trial Finds New Bladder Cancer Treatment Safe 13 March
Trial finds new bladder cancer treatment safe
Lab-grown tumours predict treatment outcomes in landmark study
Rottnest Island’s golfing challenge raises over $38,000
New therapy will revolutionise treatment of urothelial and bladder cancers
Caz’s From treatment to teatime
Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer
Cancer’s sweet Achilles heel
Cheaper medicines for cervical cancer, urotherial cancer and spinal muscle atrophy
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Why does my dog eat grass? And when is it not safe for them?
New approval for trial of Immutep’s ‘efti’ with Merck’s PD-L1 inhibitor
Researchers Identify a New Genetic Culprit in Canine Bladder Cancers
How bad is vaping and should it be banned?
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
Karen’s home away from home for Christmas
Hopetoun champion becomes face of our Christmas Appeal
Whole Exome Sequencing Predicts Whether Patients Respond to Cancer Immunotherapy
Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial
World first trial for new bladder cancer imaging scan to be presented in US
Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Transparent ultrasound chip improves cell stimulation and imaging
World-first trial of targeted bladder cancer treatment showing promise
USANZ and RACGP speak out on pharmacy pilot
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Scientists studying new method to model bladder cancer treatments
Cancer survival rates are improving in Australia
Cancer survival rates continue to improve, while death and incidence rates fall
2022 Fellowships to support improved health outcomes for cancer patients
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Tonsley takes Flinders on steep learning curve
Heartburn treatment a poor match to cancer drug
Antibiotic overuse reduces bladder cancer survival